tradingkey.logo
搜尋

Catheter Precision Inc

VTAK
添加自選
0.252USD
-0.026-9.36%
收盤 07-31 16:00美東報價延遲15分鐘
677.70K總市值
虧損本益比TTM

關於 Catheter Precision Inc 公司

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Catheter Precision Inc簡介

公司代碼VTAK
公司名稱Catheter Precision Inc
上市日期Sep 27, 2018
CEOJenkins (David A)
員工數量22
證券類型Ordinary Share
年結日Sep 27
公司地址1670 Highway 160 West
城市FORT MILL
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編29708
電話19736912000
網址https://www.ramed.com/
公司代碼VTAK
上市日期Sep 27, 2018
CEOJenkins (David A)

Catheter Precision Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--

常見問題

Catheter Precision Inc的前五大股東是誰?

Catheter Precision Inc的前五大股東如下:Mr. David Jenkins

有多少機構持有Catheter Precision Inc(VTAK)的股份?

截至2026Q1,共有28家機構持有Catheter Precision Inc的股份,合計持有的股份價值約為304.48K,占公司總股份的11.31% 。與2025Q4相比,機構持股有所增加,增幅為230261.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有